And Dai et al. recognized CDCA8 as a downstream target of transcriptional activation by transcription factor NF-Y in both human embryonic stem cells and cancer cells, demonstrating the potential regulatory mechanism of CDCA821. The gene discussed is CDCA8; the disease is cancer.